Latest

Registers› Irish medicines ›AstraZeneca AB

Medicines register · Ireland

AstraZeneca AB — licensed medicines

70 medicines held by AstraZeneca AB on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Riltrava Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension EU/1/21/1604/001-002

Formoterol fumarate dihydrate, Glycopyrronium bromide, Budesonide

—

Saphnelo 120 mg solution for injection in pre-filled pen EU/1/21/1623/003-005

Anifrolumab

—

Saphnelo 120 mg solution for injection in pre-filled syringe EU/1/21/1623/002

Anifrolumab

—

Saphnelo 300 mg Concentrate for solution for infusion EU/1/21/1623/001

Anifrolumab

—

Symbicort Turbohaler, 100 micrograms /6 micrograms/inhalation, inhalation powder PA1019/020/001

Budesonide, Formoterol fumarate dihydrate

Marketed

Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder PA1019/020/003

Budesonide, Formoterol fumatrate dihydrate

Marketed

Symbicort, 200 micrograms/6 micrograms per inhalation, pressurised inhalation, suspension PA1019/020/004

Formoterol fumarate dihydrate (micronised), Budesonide

Not marketed

Symbicort® Turbohaler; 200 micrograms/6 micrograms/inhalation, inhalation powder PA1019/020/002

Budesonide, Formoterol fumatrate dihydrate

Marketed

Synagis 50 mg/0.5 ml and 100 mg/1 ml Solution for injection EU/1/99/117/003-004

Palivizumab

—

TAGRISSO 40 mg film-coated tablets EU/1/16/1086/001

Osimertinib mesylate

—

TAGRISSO 80 mg film-coated tablets EU/1/16/1086/002

Osimertinib mesylate

—

Tezspire 210 mg solution for injection in pre-filled syringe EU/1/22/1677/001-002

Tezepelumab

—

Trixeo Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension EU/1/20/1498/002-003

Budesonide micronised, Glycopyrronium bromide, Formoterol fumarate dihydrate (micronised)

—

TRUQAP 160 mg film-coated tablets EU/1/24/1820/001

Capivasertib

—

TRUQAP 200 mg film-coated tablets EU/1/24/1820/002

Capivasertib

—

Wainzua 45 mg solution for injection in pre-filled pen EU/1/24/1875/001

Eplontersen sodium

—

Xigduo 5 mg/1000 mg film-coated tablets EU/1/13/900/007-012

Metformin Hydrochloride, Dapagliflozin propanediol monohydrate

—

Xigduo 5 mg/850 mg film-coated tablets EU/1/13/900/001-006

Dapagliflozin propanediol monohydrate, Metformin Hydrochloride

—

Zoladex 3.6 mg implant PA1019/027/001

Goserelin

Marketed

Zoladex LA 10.8 mg implant PA1019/027/002

Goserelin

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 21 September 2026. https://priyalifescience.com/medicines/company/astrazeneca-ab

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.